News About: Pharm. Industry
“Breixt will bring minor impacts on domestic health industry”
The British withdrawal from the European Union, also known as Brexit, will narrowly impact the domestic healthcare industry, while it might raise competitiveness caused by change of exchange rates instead.
Though the...
Japanese pharmaceutical companies’ sales management expenses increase every year
It was observed Japanese pharmaceutical companies’ average sales and sales management expenses(SME) are growing. When it comes to the characteristic of the domestic market focusing on promotion and marketing activitie...
Novartis’s rebate investigation extended to professors of endocrinologyThe industry has started to concern that the investigation range of the Novartis Korea’s rebate incident which is limited to a specific field might be extended to the ‘endocrino...
|
Pharmaking to voluntarily withdraw from KPMA
Pharmaking, which arose public criticism through the CEO’s detention on suspicion of KRW 5 billion illegal rebate provision, has voluntarily withdrawn from the Korea Pharmaceutical Manufacturers Association.
The for...
Will multinational companies enter pharmaceutical bidding pool?
As soon as the Ministry of Health and Welfare decided a policy to exclude prices that were bid in the drug bidding pool for public and private hospitals from drug price cuts, multinational pharmaceutical companies hav...
Daiichi Sankyo’s takeover of ‘Effient’ licenseDaiichi Sankyo Korea(CEO Dae-joon Kim) announced a transfer of the product right of an oral antiplatelet agent, ‘Effient(generic name: prasugrel),’ from Lilly Korea as of the 13...
|
Will Pradaxa catch up with launching it as reversal agent?
Novel oral anticoagulants(NOAC) have started to be ranked in a year after they were applied for the National Health Insurance as the primary treatment for stroke prevention in treating stroke and embolism for atrial f...
Pharmaceutical industry shows embarrassment over prosecution’s inspections
The prosecution’s rebate inspections over pharmaceutical companies and doctors have taken unexpected directions.
This is because the prosecution pushed forward with search and seizure on a well-known pharmaceutical c...
LG Life Sciences conclude joint sales agreement of Micera with Roche Korea
On the 11th, LG Life Sciences(CEO Il-jae Jung) and Roche Korea(CEO Matt Sause) announced conclusion of the joint sales agreement of Mircera, a anemia treatment for chronic kidney disease patients. Micera is a product ...
Pfizer Pharmaceuticals Korea divided into ‘Pharmaceutical’ & ‘PFE’Pfizer Pharmaceuticals Korea(CEO Dong-uk Oh) announced change of business and corporate operation plans in terms of the Pfizer headquarters’ reorganization.
The Pfizer Pharmace...
|
